NVision
NVision engineers molecular quantum systems for quantum-enhanced metabolic MRI and photonic-interfaced quantum computing.
- 148
- Private company
- Ulm, BW, DEGermany
NVision engineers molecular quantum systems for quantum-enhanced metabolic MRI and photonic-interfaced quantum computing.
nvision-quantum.comCrawled Oct 15, 2026
NVision Quantum shares news and announcements about quantum computing (PIQC) and quantum-enhanced MRI (POLARIS).
The EuroHPC Joint Undertaking selected NVision Quantum Technologies among 13 companies for funding under its Quantum Grand Challenge; NVision is the only selected German company pursuing a spin-qubit architecture.
NVision Quantum Technologies deployed its POLARIS platform at Hokkaido University, its first deployment in Japan; the system is installed in the university's Division of Bioengineering and Bioinformatics.
NVision Quantum uses quantum spin control in organic molecules for quantum computing and enhanced sensing.
NVision Quantum offers quantum computing and quantum-enhanced MRI technologies and invites partnership inquiries.
NVision Quantum leads the transformation in quantum computing and quantum-enhanced sensing by mastering quantum spin control to accelerate scientific discovery.
A consortium led by **University College London** and **NVision & Gold Standard Phantoms** is developing **CHARM**, a calibration framework to standardize MRI scan consistency globally. The solution aims to improve cross-site comparability in medical imaging by aligning protocols and equipment performance. CHARM integrates phantom-based calibration to reduce variability in diagnostic accuracy.
Oct 2026Quantum ZeitgeistNews article
NVision Quantum Technologies is entering quantum computing hardware with its **PIQC (Photonic Integrated Quantum Chip)** architecture, combining synthetic organic molecules and silicon photonic chips. The system targets scalable, photonically-entangled quantum gates for fault-tolerant computing, leveraging the company’s prior success in hyperpolarized MRI platforms. The approach integrates optically addressable spin states into photonic chips to enable molecular quantum operations.
Oct 2026Quantum Computing ReportNews article
NVision deploys its quantum-enhanced MRI platform, **POLARIS**, at **UCLouvain** to investigate cancer metabolism in real time. The system targets **melanoma, triple-negative breast cancer, and metastatic disease**, aiming to improve understanding of treatment response and resistance mechanisms. Researchers will leverage quantum technology to refine diagnostic and therapeutic approaches.
Oct 2026WebDisclosureNews article
NVision is selected for Phase 1 of the EuroHPC Joint Undertaking Quantum Grand Challenge with its QOSMOS project. Over a four-month period, the QOSMOS project develops a roadmap to scale NVision’s photon-interfaced molecular spin-qubit architecture toward an error-corrected quantum computing platform.
Sep 2026The Quantum InsiderNews article